• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环神经肽 Y 可能是诊断心房颤动的生物标志物。

Circulating Neuropeptide Y May Be a Biomarker for Diagnosing Atrial Fibrillation.

机构信息

Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China,

Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.

出版信息

Cardiology. 2023;148(6):517-527. doi: 10.1159/000533405. Epub 2023 Aug 4.

DOI:10.1159/000533405
PMID:37544294
Abstract

INTRODUCTION

Sympathetic nervous system disorder promotes atrial fibrillation (AF), and neuropeptide Y (NPY) is an important neurotransmitter. This study aimed to explore the predictive value of plasma NPY in patients with AF.

METHODS

Five hundred seventy-six patients were divided into AF (including paroxysmal and long-standing persistent AF; 360) and sinus rhythm (SR) groups (216). NPY level was detected using enzyme-linked immunosorbent assay, and NPY mRNA expression level was detected using quantitative polymerase chain reaction. Logistic regression was used to analyse the risk factors for AF; the correlations between blood NPY level and age, body mass index (BMI), left ventricular ejection fraction, left atrial diameter (LAD), and European Heart rate Association (EHRA) score in patients with AF were determined. The receiver operating characteristic (ROC) curve was utilised to predict AF.

RESULTS

Plasma NPY levels were found to be higher in patients with AF than in patients with SR and in patients with long-standing persistent AF than in patients with paroxysmal AF; blood NPY mRNA levels were higher in the paroxysmal and long-standing persistent AF groups compared to the SR group (p < 0.05). Increased age {odds ratio (OR) = 1.201 (95% confidence interval [CI]: 1.01, 1.427)} and high NPY [OR = 1.239 (95% CI: 1.022, 1.501)] were factors found to affect AF detrimentally. NPY was associated with BMI (r = 0.5856, p < 0.05), LAD (r = 0.4023, p < 0.05), and EHRA score (r = 0.898, p < 0.05). The ROC curve for the predictive value of plasma NPY levels for AF showed an area under the curve (AUC) value of 0.919 (p < 0.05), while that for long-standing persistent AF showed an AUC of 0.784 (p < 0.05).

CONCLUSION

Circulating NPY may be a promising molecular biomarker of AF.

摘要

简介

交感神经系统紊乱可促进心房颤动(AF)发生,而神经肽 Y(NPY)是一种重要的神经递质。本研究旨在探讨血浆 NPY 对 AF 患者的预测价值。

方法

将 576 例患者分为 AF(包括阵发性和持续性持久性 AF;360 例)和窦性节律(SR)组(216 例)。采用酶联免疫吸附试验检测 NPY 水平,采用定量聚合酶链反应检测 NPY mRNA 表达水平。采用 Logistic 回归分析 AF 的危险因素;分析 AF 患者血液 NPY 水平与年龄、体重指数(BMI)、左心室射血分数、左心房直径(LAD)和欧洲心律协会(EHRA)评分的相关性。利用受试者工作特征(ROC)曲线预测 AF。

结果

与 SR 组相比,AF 患者的血浆 NPY 水平较高,持续性持久性 AF 患者的血浆 NPY 水平高于阵发性 AF 患者;与 SR 组相比,阵发性和持续性持久性 AF 组的血液 NPY mRNA 水平较高(p < 0.05)。年龄增加(优势比[OR] = 1.201(95%置信区间[CI]:1.01,1.427))和 NPY 升高[OR = 1.239(95% CI:1.022,1.501)]是影响 AF 的不利因素。NPY 与 BMI(r = 0.5856,p < 0.05)、LAD(r = 0.4023,p < 0.05)和 EHRA 评分(r = 0.898,p < 0.05)相关。血浆 NPY 水平对 AF 的预测价值的 ROC 曲线下面积(AUC)值为 0.919(p < 0.05),而对持续性持久性 AF 的 AUC 值为 0.784(p < 0.05)。

结论

循环 NPY 可能是 AF 的一种有前途的分子生物标志物。

相似文献

1
Circulating Neuropeptide Y May Be a Biomarker for Diagnosing Atrial Fibrillation.循环神经肽 Y 可能是诊断心房颤动的生物标志物。
Cardiology. 2023;148(6):517-527. doi: 10.1159/000533405. Epub 2023 Aug 4.
2
Risk factors for recurrence of persistent atrial fibrillation after radiofrequency ablation and correlation with plasma miRNA expression.射频消融术后持续性心房颤动复发的危险因素及其与血浆微小RNA表达的相关性
Minerva Cardiol Angiol. 2025 Apr 23. doi: 10.23736/S2724-5683.24.06402-0.
3
Serum miR-15a-5p may predict recurrence of atrial fibrillation after catheter ablation: a single center retrospective study.血清miR-15a-5p可能预测导管消融术后房颤复发:一项单中心回顾性研究。
PeerJ. 2025 Jul 3;13:e19618. doi: 10.7717/peerj.19618. eCollection 2025.
4
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
5
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
6
Association of HARMS-AF score with atrial tachyarrhythmia recurrence after radiofrequency catheter ablation: a retrospective observational study.HARMS-AF评分与射频导管消融术后房性快速性心律失常复发的相关性:一项回顾性观察研究。
BMC Cardiovasc Disord. 2025 Aug 28;25(1):636. doi: 10.1186/s12872-025-05110-y.
7
External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.体外电复律和药物复律治疗心房颤动、心房扑动或房性心动过速的网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD013255. doi: 10.1002/14651858.CD013255.pub2.
8
Insulin resistance, left atrial anatomical remodeling, and recurrence in patients with atrial fibrillation undergoing radiofrequency ablation.接受射频消融术的心房颤动患者的胰岛素抵抗、左心房解剖结构重塑与复发情况
Eur J Med Res. 2025 Aug 29;30(1):819. doi: 10.1186/s40001-025-03093-2.
9
[Applicability of HFPEF and HFA-PEFF Scores in Chinese Patients Suffering From Heart Failure With Preserved Ejection Fraction and Heart Failure With Preserved Ejection Fraction Complicated With Atrial Fibrillation].[射血分数保留的心力衰竭及合并心房颤动的射血分数保留的心力衰竭患者中HFPEF和HFA-PEFF评分的适用性]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Apr;46(2):154-160. doi: 10.3881/j.issn.1000-503X.15826.
10
Non-invasive prediction of atrial cardiomyopathy characterized by multipolar high-density contact mapping.基于多极高密度接触标测的心房心肌病无创预测
J Interv Card Electrophysiol. 2025 Feb 3. doi: 10.1007/s10840-025-02001-2.

引用本文的文献

1
Ropivacaine combined with esketamine in ultrasound-guided thoracic paravertebral nerve block in lung cancer patients undergoing thoracoscopic radical surgery.罗哌卡因联合艾司氯胺酮用于胸腔镜根治性手术肺癌患者的超声引导下胸椎旁神经阻滞
Discov Oncol. 2025 Jun 11;16(1):1053. doi: 10.1007/s12672-025-02762-2.